Keratinocyte growth factor facilitates alloengraftment and ameliorates graft-versus-host disease in mice by a mechanism independent of repair of conditioning-induced tissue injury

Blood

Volumn 96, Issue 13, 2000, Pages 4350-4356

  Panoskaltsis Mortari, Angela ^a   Taylor, Patricia A ^b   Rubin, Jeffrey S ^b   Uren, Aykut ^b   Welniak, Lisbeth A ^b   Murphy, William J ^b   Farrell, Catherine L ^b   Lacey, David L ^b   Blazar, Bruce R ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FGF7 PROTEIN, MOUSE; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 10; GAMMA INTERFERON; GROWTH PROMOTOR; INTERLEUKIN 13; KERATINOCYTE GROWTH FACTOR; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BLOOD; BONE MARROW TRANSPLANTATION; C57BL MOUSE; DRUG EFFECT; DRUG SCREENING; EPITHELIUM CELL; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; IMMUNIZATION; IMMUNOSUPPRESSIVE TREATMENT; MIXED LYMPHOCYTE CULTURE; MOUSE; MOUSE MUTANT; RADIATION CHIMERA; RADIATION EXPOSURE; RADIATION INJURY; SECRETION; TH2 CELL; WHOLE BODY RADIATION;

ANIMALS; BONE MARROW TRANSPLANTATION; DRUG EVALUATION, PRECLINICAL; EPITHELIAL CELLS; FIBROBLAST GROWTH FACTOR 10; FIBROBLAST GROWTH FACTOR 7; FIBROBLAST GROWTH FACTORS; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; GROWTH SUBSTANCES; IMMUNIZATION; INTERFERON TYPE II; INTERLEUKIN-13; LYMPHOCYTE CULTURE TEST, MIXED; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, SCID; RADIATION CHIMERA; RADIATION INJURIES, EXPERIMENTAL; RECOMBINANT PROTEINS; TH2 CELLS; TRANSPLANTATION CONDITIONING; TUMOR NECROSIS FACTOR-ALPHA; WHOLE-BODY IRRADIATION;

EID: 0034672365     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.13.4350.h8004350_4350_4356     Document Type: Article

References (17)

1. Rubin, JS, Osada H, Finch PW, Taylor WG, Rudikoff S, Aaronson SA. Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc Natl Acad Sci USA. 1989;86:802-806.
2. Finch PW, Rubin JS, Miki T, Ron D, Aaronson SA. Human KGF is FGF-related with properties of a paracrine effector of epithelial growth. Science. 1989;245:752-755.
3. Farrell CL, Bready JV, Rex KL, et al. Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality. Cancer Res. 1998;58:933-939.
4. Ulich TR, Whitcomb L, Tang W, et al. Keratinocyte growth factor ameliorates cyclophosphamide-induced ulcerative hemorrhagic cystitis. Cancer Res. 1997;57:472-475.
5. Yi ES, Williams ST, Lee H, et al. Keratinocyte growth factor ameliorates radiation- and bleomycin-induced lung injury and mortality. Am J Pathol. 1996;149:1963-1970.
6. Danilenko DM. Preclinical and early clinical development of keratinocyte growth factor, an epithelial-specific tissue growth factor. Toxicol Pathol. 1999;27:64-71.
7. Panoskaltsis-Mortari A, Lacey DL, Vallera DA, Blazar BR. Keratinocyte growth factor administered before conditioning ameliorates graft-versus-host disease after allogeneic bone marrow transplantation in mice. Blood. 1998;92:3960-3967.
8. Haddad IY, Panoskaltsis-Mortari A, Ingbar DH, et al. Interactions of keratinocyte growth factor with a nitrating species after marrow transplantation in mice. Am J Physiol Lung Cell Mol Physiol. 1999;277:L391-L400.
9. Panoskaltsis-Mortari A, Ingbar DH, Jung P, et al. Keratinocyte growth factor (KGF) given before conditioning decreases B7 ligand and grarizyme B expression in situ and hastens lung repair post-allogeneic bone marrow transplantation (BMT) in mice. Am J Physiol Lung Cell Mol Physiol. 2000;278:L988-L999.
10. Clark JG, Hansen JA, Hertz MI, Parkman R, Jensen L, Peavy HH. Idiopathic pneumonia syndrome after bone marrow transplantation. Am Rev Respir Dis. 1993;147:1601-1606.
11. Blazar BR, Korngold R, Vallera DA. Recent advances in graft-versus-host disease (GVHD) prevention. Immunol Rev. 1997;157:79-109.
12. Krijanovski OI, Hill GR, Cooke KR, et al. Keratinocyte growth factor separates graft-versus-leukemia effects from graft-versus-host disease. Blood. 1999;94:825-831.
13. Ulich TR, Yi ES, Longmuir K, et al. Keratinocyte growth factor is a growth factor for type II pneumocytes in vivo. J Clin Invest. 1994;93:1298-1306.
14. Blazar BR, Taylor PA, Linsley PS, Vallera DA. In vivo blockade of CD28/CTLA4:B7/BB1 interaction with CTLA4-Ig reduces lethal murine graft-versus-host disease across the major histocompatibility complex (MHC) barrier in mice. Blood. 1994;83:3815-3825.
15. + cells. J Immunol. 1996;157:3250-3259.
16. Bottaro DP, Rubin JS, Ron D, Finch PW, Florio C, Aaronson SA. Characterization of the receptor for keratinocyte growth factor: evidence for multiple fibroblast growth factor receptors. J Biol Chem. 1990;265:12767-12770.
17. Winkles JA, Alberts GF, Chedid M, Taylor WG, DeMartino S, Rubin JS. Differential expression of the keratinocyte growth factor (KGF) and KGF receptor genes in human vascular smooth muscle cells and arteries. J Cell Physiol. 1997;173:380-386.